Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

World Heart

This article was originally published in The Gray Sheet

Executive Summary

Grosses about $14.2 mil. in private placement of 2.1 mil. special warrants at $6.80 each through agents Midland Walwyn Capital and ScotiaMcleod. The warrants are exercisable for 2.1 mil. shares of common stock "without additional consideration," the firm states. Net proceeds will be used for initial production, clinical trials and commercialization of the Ottawa, Ontario firm's HeartSaver fully implantable ventricular assist device ("The Gray Sheet" Dec. 23, 1996, I&W-10). Funds from the offering are anticipated to be "sufficient to conduct the business of the company, including clinical trials in Canada, through the year 2000," World Heart states...
UsernamePublicRestriction

Register

MT010283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel